High drug prices are not justified by industry’s spending on research and development
Angelis, A.
, Polyakov, R., Wouters, O. J., Torreele, E. & McKee, M.
(2023).
High drug prices are not justified by industry’s spending on research and development.
BMJ,
380(8371).
https://doi.org/10.1136/bmj-2022-071710
, Polyakov, R., Wouters, O. J., Torreele, E. & McKee, M.
(2023).
High drug prices are not justified by industry’s spending on research and development.
BMJ,
380(8371).
https://doi.org/10.1136/bmj-2022-071710
Aris Angelis and colleagues argue that by refocusing their spending drug companies could provide more innovative drugs at affordable prices